📰 Midatech Pharma News
Midatech Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Midatech Pharma. Real-time updates on events, politics, business and more.
March 28, 2024
/PRNewswire/ -- The HDAC (histone deacetylase) Inhibitors Market by Route of Administration, Distribution Channel, and Geography - Forecast and Analysis...
February 19, 2024
DUBLIN--(BUSINESS WIRE)--The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.com's offering.Large pharmaceutical and biotechnology companies are increasingly pursuing in-licensing to offset lower than expected drug development productivity and surging research costs. Data mining...
February 16, 2024
/PRNewswire/ -- The "Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.coms...
February 14, 2024
/PRNewswire/ -- The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.coms offering. Large pharmaceutical and...
February 11, 2024
Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 18 ($0.23) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of […]
February 3, 2024
Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 18 ($0.23) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares. Biodexa […]
January 22, 2024
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones...
August 30, 2023
The coacervation provides various benefits including improved effectiveness, fewer side effects, convenience, and guaranteed linear medication...
July 2, 2023
Biodexa Pharmaceuticals Plc (LON:MTPH – Free Report)’s stock price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 13.26 ($0.17) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares trading […]
June 20, 2023
NEW HAVEN, Conn., June 20, 2023 -- BIOASIS TECHNOLOGIES INC. , a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor... | June 20, 2023